- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Angers - CHU Angers, France
- Bayonne - CH Bayonne, France
- Boulogne - Ambroise Paré Boulogne, France
- Lyon - URCOT Bron, France
Clinical trial condition
EGFR L858R
Explore clinical trials studying EGFR L858R. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
EGFR L858R trial results
NCT07461727
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
Not specified
NCT05263947
- Conditions
- Bevacizumab, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
Active, Not Recruiting
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy
NCT05338970
- Conditions
- EGFR Exon 19 Deletion, EGFR L858R, Nonsquamous Non-small Cell Lung Cancer
- Locations
-
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
- Highlands Oncology Springdale, Arkansas, United States
- City of Hope Duarte, California, United States
- Moores Cancer Center at the UC San Diego Health La Jolla, California, United States